Immix Biopharma Inc. (IMMX)
NASDAQ: IMMX
· Real-Time Price · USD
2.27
0.08 (3.65%)
At close: Aug 15, 2025, 3:59 PM
2.27
0.00%
After-hours: Aug 15, 2025, 04:27 PM EDT
Immix Biopharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 11.64M | 15.92M | 17.68M | 19.69M | 23.98M | 29.32M | 17.51M | 19.58M | 12.65M | 11.46M | 13.44M | 16.92M | 18.4M | 19.06M | 17.64M | 37.99K | 110.6K | -391.09K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 782.17K |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 131.02K | 20.42K | 20.42K | 20.42K | 20.42K | 20.42K | 87.23K | 103.19K | 56.72K | 175.13K | 6.72K | 0.00 | n/a | n/a | n/a | 246.02K | 52.67K | -391.09K |
Receivables | n/a | n/a | 1.97M | 1.98M | 1.98M | 2.02M | 1.17M | 652.48K | 297K | 322.38K | 255.71K | 182.34K | 165.05K | 63.73K | 25.72K | 188.63K | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25.72K | n/a | n/a | n/a |
Other Current Assets | 687.51K | 168.4K | 32.27K | 36.52K | 105.78K | 175.25K | 44.58K | 167K | 2.56M | 1.25M | 78.07K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 12.33M | 16.78M | 20.2M | 22.76M | 27.33M | 32.92M | 19.79M | 22.33M | 15.51M | 13.03M | 14.9M | 17.39M | 19.08M | 20.01M | 18.19M | 242.92K | 291.97K | 391.09K |
Property-Plant & Equipment | 3.18M | 3.09M | 2.73M | 2.37M | 1.48M | 1.41M | 50.18K | 40.08K | 2.55K | 3.06K | 3.56K | 4.13K | 4.69K | 5.08K | 5.7K | 6.32K | 6.93K | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 3.31M | 3.11M | 2.75M | 2.39M | 1.51M | 1.43M | 137.41K | 143.27K | 59.27K | 178.19K | 10.28K | 4.13K | 4.69K | 5.08K | 5.7K | 252.34K | 59.61K | -391.09K |
Total Assets | 15.64M | 19.89M | 22.95M | 25.14M | 28.84M | 34.35M | 19.93M | 22.47M | 15.57M | 13.21M | 14.91M | 17.4M | 19.09M | 20.02M | 18.19M | 495.26K | 351.58K | n/a |
Account Payables | 6.61M | 5.74M | 5.39M | 3.29M | 2.35M | 3.51M | 1.43M | 1.57M | 2.4M | 1.47M | 143.07K | 646.46K | 977.21K | 305.68K | 142.94K | 618.03K | 182.78K | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | -48.36K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -192.94K | 435.99K | 402.77K | n/a |
Short-Term Debt | 70.47K | 67.82K | 65.22K | 62.72K | 48.36K | 34.28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50K | 50K | 4.1M | 4.1M | n/a |
Other Current Liabilities | 3.32M | 663.98K | -65.22K | 135.38K | n/a | -34.28K | n/a | 1.13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.31M | 1.31M | n/a |
Total Current Liabilities | 10.01M | 9.31M | 8.69M | 6.56M | 3.9M | 5.66M | 3.72M | 2.83M | 2.4M | 1.47M | 1.27M | 646.46K | 977.21K | 365.09K | 202.04K | 6.46M | 6M | n/a |
Long-Term Debt | 972.34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 146.94K | 126.81K | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 475K | n/a | n/a | n/a | n/a | 80K | 80K | n/a |
Total Long-Term Liabilities | 972.34K | 991.13K | 1.01M | 1.03M | 1.04M | 1.06M | n/a | n/a | n/a | n/a | 475K | 646.46K | n/a | 355.68K | n/a | 226.94K | 206.81K | n/a |
Total Liabilities | 10.98M | 10.3M | 9.7M | 7.59M | 4.94M | 6.72M | 3.72M | 2.83M | 2.4M | 1.47M | 1.75M | 646.46K | 977.21K | 365.09K | 202.04K | 6.69M | 6.2M | n/a |
Total Debt | 1.04M | 1.06M | 1.07M | 1.09M | 1.09M | 1.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50K | 50K | 4.25M | 4.23M | n/a |
Common Stock | 2.85K | 2.79K | 2.76K | 2.76K | 2.75K | 2.65K | 2K | 1.97K | 1.63K | 1.4K | 1.4K | 1.4K | 1.4K | 1.39K | 1.32K | 338.00 | 338.00 | n/a |
Retained Earnings | -86.19M | -79.57M | -75.02M | -70.21M | -63.06M | -58.67M | -53.41M | -48.32M | -44.04M | -40.46M | -37.99M | -34.19M | -32.65M | -31.09M | -29.76M | -7M | -6.6M | n/a |
Comprehensive Income | 65.03K | 15.46K | -1.06K | 192.05K | 116.97K | 89.61K | 134.67K | 46.73K | 80.88K | 82.55K | 87.02K | 62.05K | 102.44K | 141K | 125.41K | 123.87K | 127.39K | -4.73M |
Shareholders Equity | 4.65M | 9.59M | 13.25M | 17.55M | 23.89M | 27.92M | 16.41M | 19.77M | 13.23M | 11.77M | 13.16M | 16.75M | 18.11M | 19.65M | 17.99M | -6.2M | -5.85M | -4.73M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 782.17K |